ESC 365 - Insights into the safety and efficacy of renal denervation.

Insights into the safety and efficacy of renal denervation.

Session: What cardiologists need to know about renal denervation (RDN) in 2013

Topic: Treatment of hypertension

Speaker: Professor F. Mahfoud (Basel, CH)

Sponsored by Medtronic

Event: ESC Congress 2013

Add to my library

About the speaker

Professor Felix Mahfoud

University Hospital Basel, Basel (Switzerland)

39 presentations

1 follower

5 more presentations in this session

Introduction.

The crisis of uncontrolled hypertension.

Speaker: Doctor C. Yancy (Chicago, US)

RDN and the sympathetic nervous system.

Speaker: Professor M. Esler (Melbourne, AU)

Which of my patients are appropriate for RDN?

Speaker: Professor R. Schmieder (Erlangen, DE)

Conclusion.

Access the full session

What cardiologists need to know about renal denervation (RDN) in 2013

Speakers: Professor F. Mahfoud, Doctor C. Yancy, Professor M. Esler, Professor R. Schmieder

About the event

ESC Congress 2013

31 August - 4 September 2013

Sessions Presentations

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources